Profit-Seeker,

There's no way around this so I just have to be blunt. There are two things that truly satisfy us: money and that three letter word that begins with s and ends in x. That's why TRTB could make you very happy.

There's so much potential for share gains here that I am calling this "My Biggest Winner Ever." It could even go beyond my ESRX recommendation—and that's hit a stunning 35,333%.

True 2 Beauty (TRTB) is a leading manufacturer and distributor of the Libigrow family of products. The product family includes pills and liquids for men and women that stir up and fulfill our strongest desires—and they're taking off like a rocket.

There are no companies I know of like TRTB that are publicly traded—and the privately-held companies in this niche supplement business spin off enormous revenues in the mlns of dollars.

This is a market worth an estimated $6 billion just for male enhance - ment pills alone.

Unlike others on the market that have been found to have pharmaceutical grade ingredients in them (an FDA flag), Libigrow comes from Mother Nature and is a safe herbal supplement. It is an all-natural alternative to the $2 billion a year "little blue pill."

Men across the country are using TRTB's Libigrow to increase blood flow to improve size and performance and to increase endurance in the bedroom. Even women are using the company's product to get fired up.

Libido lighters. Rocket boosters.
Call them what you may, they're massive cash machines

Look what "the little blue pill" did for mlns of men around the world—and look what it did for pharma giant Pfizer.

The company made $944 mln in the first six months of this year. Pfizer will have raked in close to $2 billion in just 12 months by the end of this year. (Another competitor pronounced "See Alice" from Eli Lilly pulled down $1.56 billion in 2009.)

Yet, that little blue pill has devastating side effects like risk of stroke and blindness for starters. TRTB is completely from Mother Nature and has no side effects making it a much safer alternative.

No wonder consumer and private label sales are taking off like crazy.

That's not all...
privately-held companies have created empires from these supplements

There is a competing supplement that calls itself the herbal answer to the little blue pill. It was literally built by an entrepreneur working from his garage. Today it's a $250 mln a year supplement empire.

According to the company, they've sold over 10 mln boxes of their supplement to 5 mln customers. You've probably seen their "Smiling Bob" ads.

Another competitor uses former Dallas Cowboy Coach Jimmy Johnson as its spokesperson and has inundated the market with Johnson's "Go Long" campaigns. Reliable sources report that the company did $120 mln in direct to consumer sales alone last year.

Problem is, these companies—and others like them—are privately held.

But, TRTB is a publicly traded company so we could see substantial gains in this exploding market for supplements that satisfy one of the strongest cravings on earth.

TRTB has a captive audience that could make you a fortune for years to come

Extensive research has shown that young adult males and females in their 20s are the biggest users of TRTB's products.

I like a buying demographic that spells long-term loyalty from a robust market sector. These young men and women are likely to remain loyal customers for many years. That means they'll continue to boost revenues for TRTB while continuously increasing shareholder value.

Your $0.18 a share buy today could well be worth 25, 50 even 150 times your investment in the coming months.

Talk to your broker today about buying shares in TRTB before the share price soars up the charts and before you miss out on the next little blue pill profit machine. Learn more about TRTB's potential in my Special Report.

TRTB is on the move
Sales already hit $10 mln in just 6 months

Ten mln dollars in sales in just 6 months is an incredible showing for a young company—especially when you consider that all advertising has been word of mouth or viral up until now.

As the company gears up to roll out its national advertising campaign soon, imagine how the sales will rocket. That's why you want to be invested now. Share price for TRTB is currently in the $0.18 range.

Company management projects that consumer sales will hit $30 mln in the coming 24 weeks—there's an entire market waiting to bust wide open as TRTB expands into new markets.

Expanding distribution leading to a boom in sales

Already 7 master distributors and numerous wholesale distributors are in place around the country and there is a long list of customers using TRTB's products that is increasing by the day.

I expect several major announcements about the company's growth and expansion to be publicized soon.

You want to buy shares before that happens. Come early 2011, things are going to explode for TRTB based on confidential information shared with me by the company.

Learn more about TRTB's distributor deals in my Special Online Report that details much more about the company and its growth.

$5 mln to expand operations already in hand

Recently, the company received the first $2.3 mln of a total $5 mln in private placement funds. That $5 mln will be used to increase production from 1 mln pills a month to a whopping 20 mln pills a month allowing TRTB to meet the crushing market demand.

Clearly there is tremendous demand for TRTB's enhance - ment supplements. My Special Online Report details how this explosive market could make you a fortune.

The ability to invest in these types of enhance - ment supplement companies are rare—yet, the market is staggering.

Knowing how strong the demand is for these products, and seeing the forces at work that are going to drive TRTB's growth, I urge you to read my Special Report and talk to your advisor about adding shares to your portfolio today.

Yours in profit-making,

Geoffrey Eiten
Publisher, OTC Growth Stock Watch